Cover Image

Risk of invasive prostate cancer and prostate cancer death in relatives of patients with prostatic borderline or in situ neoplasia: a nationwide cohort study

The question of whether having a family history of prostatic borderline or in situ neoplasia (PBISN) is associated with an increased risk of invasive prostate cancer (PCa) or death from PCa remains unanswered. The objective of the current study was to provide an evidence-based risk estimation for th...

Full description

Saved in:
Bibliographic Details
Main Authors: Xu, Xing (Author) , Fallah, Mahdi (Author) , Tian, Yu (Author) , Mukama, Trasias (Author) , Sundquist, Kristina (Author) , Sundquist, Jan (Author) , Brenner, Hermann (Author) , Kharazmi, Elham (Author)
Format: Article (Journal)
Language:English
Published: 22 July 2020
In: Cancer
Year: 2020, Volume: 126, Issue: 19, Pages: 4371-4378
ISSN:1097-0142
DOI:10.1002/cncr.33096
Online Access:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1002/cncr.33096
Verlag, lizenzpflichtig, Volltext: https://acsjournals.onlinelibrary.wiley.com/doi/abs/10.1002/cncr.33096
Get full text
Author Notes:Xing Xu, Mahdi Fallah, Yu Tian, Trasias Mukama, Kristina Sundquist, Jan Sundquist, Hermann Brenner, and Elham Kharazmi
Description
Summary:The question of whether having a family history of prostatic borderline or in situ neoplasia (PBISN) is associated with an increased risk of invasive prostate cancer (PCa) or death from PCa remains unanswered. The objective of the current study was to provide an evidence-based risk estimation for the relatives of patients with PBISN.
Item Description:Gesehen am 19.08.2020
Physical Description:Online Resource
ISSN:1097-0142
DOI:10.1002/cncr.33096

Similar Items